| Dr Lori Leah Olson, MD | |
|
Ku Medical Center Division Of General &, 3901 Rainbow Blvd, Ms 1020, Kansas City, KS 66160-0001 | |
| (913) 588-6005 | |
| (913) 588-3877 |
| Full Name | Dr Lori Leah Olson |
|---|---|
| Gender | Female |
| Speciality | Hospice/palliative Care |
| Experience | 16 Years |
| Location | Ku Medical Center Division Of General &, Kansas City, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720254055 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 04-35774 (Kansas) | Secondary |
| 207RH0002X | Internal Medicine - Hospice And Palliative Medicine | 04-35774 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
News Archive
Emergency room visits and hospitalizations of children with severe, potentially life-threatening food allergy reactions increased nearly 30 percent in Illinois over five years, reports a Northwestern Medicine study.
Look at a middle school assembly - during their lifetime one in 50 of these kids will develop melanoma, the most serious form of skin cancer that kills 48,000 people every year, worldwide. Now look at these kids again - which are at highest risk? You can't tell, but a study recently published in the Journal of the American Academy of Dermatology shows that UV photography might provide important information about risk, not visible to the naked eye.
Horizon Pharma, Inc. a biopharmaceutical company developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases, today announced that it entered into an exclusive agreement with Grunenthal for the commercialization of DUEXIS in Latin America.
The health of the public is being put at risk by recommendations to cover up and stay out of the sun in the UK. These recommendations, which are part of Cancer Research UK's SunSmart programme, increase the risk of several types of cancer, and may also increase deaths from melanoma, the most serious form of skin cancer.
INC Research®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, is pleased to announce that Trusted Process® thought leaders at INC Research were named winners at the 2009 Clinical Research Excellence Awards in London on October 20.
› Verified 2 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
Emergency room visits and hospitalizations of children with severe, potentially life-threatening food allergy reactions increased nearly 30 percent in Illinois over five years, reports a Northwestern Medicine study.
Look at a middle school assembly - during their lifetime one in 50 of these kids will develop melanoma, the most serious form of skin cancer that kills 48,000 people every year, worldwide. Now look at these kids again - which are at highest risk? You can't tell, but a study recently published in the Journal of the American Academy of Dermatology shows that UV photography might provide important information about risk, not visible to the naked eye.
Horizon Pharma, Inc. a biopharmaceutical company developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases, today announced that it entered into an exclusive agreement with Grunenthal for the commercialization of DUEXIS in Latin America.
The health of the public is being put at risk by recommendations to cover up and stay out of the sun in the UK. These recommendations, which are part of Cancer Research UK's SunSmart programme, increase the risk of several types of cancer, and may also increase deaths from melanoma, the most serious form of skin cancer.
INC Research®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, is pleased to announce that Trusted Process® thought leaders at INC Research were named winners at the 2009 Clinical Research Excellence Awards in London on October 20.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lori Leah Olson, MD Kansas University Of Physicians Inc, 3901 Rainbow Blvd, 4070 Delp, Ms 4017, Kansas City, KS 66160-0001 Ph: (913) 588-2500 | Dr Lori Leah Olson, MD Ku Medical Center Division Of General &, 3901 Rainbow Blvd, Ms 1020, Kansas City, KS 66160-0001 Ph: (913) 588-6005 |
News Archive
Emergency room visits and hospitalizations of children with severe, potentially life-threatening food allergy reactions increased nearly 30 percent in Illinois over five years, reports a Northwestern Medicine study.
Look at a middle school assembly - during their lifetime one in 50 of these kids will develop melanoma, the most serious form of skin cancer that kills 48,000 people every year, worldwide. Now look at these kids again - which are at highest risk? You can't tell, but a study recently published in the Journal of the American Academy of Dermatology shows that UV photography might provide important information about risk, not visible to the naked eye.
Horizon Pharma, Inc. a biopharmaceutical company developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases, today announced that it entered into an exclusive agreement with Grunenthal for the commercialization of DUEXIS in Latin America.
The health of the public is being put at risk by recommendations to cover up and stay out of the sun in the UK. These recommendations, which are part of Cancer Research UK's SunSmart programme, increase the risk of several types of cancer, and may also increase deaths from melanoma, the most serious form of skin cancer.
INC Research®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, is pleased to announce that Trusted Process® thought leaders at INC Research were named winners at the 2009 Clinical Research Excellence Awards in London on October 20.
› Verified 2 days ago
Micholee Beth Polsak, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, 6040 Delp, Ms 1020, Kansas University Physicians Inc, Kansas City, KS 66160 Phone: 913-588-3974 Fax: 913-588-6055 | |
Ira William Marsh, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 8929 Parallel Pkwy, Kansas City, KS 66112 Phone: 913-596-4000 | |
Dr. Tara L Lin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6030 Fax: 913-588-4085 | |
Kristin N Fee, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd # Ms 2027, Kansas City, KS 66160 Phone: 913-588-3974 Fax: 913-588-6055 | |
Donald J. Mcsweyn, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8919 Parallel Pkwy, Suite 580, Kansas City, KS 66112 Phone: 913-596-7224 Fax: 913-596-7257 | |
Dr. Dhanunjaya Lakkireddy, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Suite#g600, Kansas City, KS 66160 Phone: 913-588-9600 Fax: 913-588-9770 | |
Archana Pareek, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, 6040 Delp, Ms 1020, Division Of General And Geriatric Medicine, University, Kansas City, KS 66160 Phone: 913-588-6005 Fax: 913-588-3877 |